Predicate |
Object |
contentType |
Comment|Journal Article |
endingPage |
85 |
issn |
1745-8366 1745-8374 |
issueIdentifier |
2 |
pageRange |
84-85 |
publicationName |
Nature clinical practice. Endocrinology & metabolism |
startingPage |
84 |
bibliographicCitation |
Tesfaye S. Is epalrestat an effective treatment for diabetic peripheral neuropathy? Nat Clin Pract Endocrinol Metab. 2007 Feb;3(2):84–5. doi: 10.1038/ncpendmet0395. PMID: 17228293. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_106d287fefe91161cc322ba340708084 |
date |
2007-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://doi.org/10.1038/ncpendmet0395 https://pubmed.ncbi.nlm.nih.gov/17228293 |
isPartOf |
https://portal.issn.org/resource/ISSN/1745-8374 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/33018 https://portal.issn.org/resource/ISSN/1745-8366 |
language |
English |
source |
https://www.crossref.org/ https://scigraph.springernature.com/ https://pubmed.ncbi.nlm.nih.gov/ |
title |
Is epalrestat an effective treatment for diabetic peripheral neuropathy? |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8854 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1549120 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7440 |